Published in Lab Business Week, April 8th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Endovasc.
Report 1: Endovasc, Inc. (EVSC), a business development company focused on acquiring and investing in companies engaged in the development of innovative cardiovascular and metabolic drugs as well as nutraceutical supplements, is pleased to announce the appointment of Sam Lindsey as the company's new chief financial officer and chief compliance officer.
The appointment was effective January 5, 2007.
Lindsey brings over 35 years of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.